Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 2 subfamily AT member 2 pseudogene (OR2AT2P) is a human gene that is classified as a pseudogene, meaning it does not encode a functional protein product[4][5]. Olfactory receptor genes typically code for G protein-coupled receptors involved in odor recognition and signal transduction in the nose, but this particular gene has lost that function due to mutations or gene-disabling events[4][5][3]. The olfactory receptor gene family is the largest in the human genome, with many members rendered inactive as pseudogenes, a common phenomenon attributed to decreased evolutionary pressure to retain functionally redundant or unnecessary olfactory receptors in humans[5]. OR2AT2P does not have a known role in disease, physiology, or as a target for drugs, and it is not considered a therapeutic target[4][5].
Not applicable (no active protein product)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 2 subfamily AT member 2 pseudogene (OR2AT2P).